Dr. Reddy'S Labs Key Ratios
NSE: DRREDDY | BSE: 500124
₹1,177.00
As on 27-Aug-2026IST
Market cap
₹98,075 Cr
Revenue (TTM)
₹33,228 Cr
P/E Ratio
30.4
P/B Ratio
2.6
Div. Yield
0.7 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 7.33 | -5.51 | -0.87 | 8.25 | 11.17 |
| EBIT | 285.17 | -80.95 | -55.06 | -21.02 | 5.95 |
| Net Profit | 101.13 | -68.67 | -43.28 | -11.97 | 13.15 |
| EPS | 101.13 | -68.67 | -43.33 | -12.05 | 13.06 |
| Book Value | -- | -- | 12.85 | 17.62 | 16.51 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 22.02 | 17.96 | 9.09 | 13.04 | 20.96 |
| Net Margin
| 19.34 | 15.11 | 9.15 | 11.86 | 16.97 |
| Return on equity
| 16.85 | 17.07 | 8.72 | 11.69 | 18.61 |
| Return on Capital
| 21.26 | 20.94 | -- | 13.75 | 23.25 |
| Return on Assets
| 13.01 | 12.12 | 5.89 | 8.03 | 13.41 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.20 | 0.14 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
13.75
|
23.25
|
26.86
|
26.22
|
|
Peer Median
|
--
|
19.34
|
21.76
|
21.89
|
--
|
ROE
8.72
Lower than Peers by 6.63
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
8.72
|
11.69
|
18.61
|
21.76
|
21.36
|
|
Peer Median
|
15.35
|
16.97
|
17.93
|
16.42
|
--
|
ROA
5.89
Lower than Peers by 4.45
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
5.89
|
8.03
|
13.41
|
16.08
|
15.01
|
|
Peer Median
|
10.35
|
9.88
|
12.81
|
12.32
|
--
|
EBIT Margin
9.09
Lower than Peers by 8.91
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
9.09
|
13.04
|
20.96
|
23.07
|
20.67
|
|
Peer Median
|
18.01
|
18.96
|
18.93
|
21.05
|
--
|
Net Margin
9.15
Lower than Peers by 5.31
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
9.15
|
11.86
|
16.97
|
19.30
|
17.52
|
|
Peer Median
|
14.45
|
13.29
|
14.94
|
15.51
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
18.45
|
22.76
|
25.16
|
23.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.87
Lower than Peers by 12.82
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
-0.87
|
3.24
|
16.54
|
13.54
|
14.50
|
|
Peer Median
|
11.95
|
12.97
|
10.90
|
13.44
|
--
|
EBIT Growth
-55.06
Lower than Peers by 76.66
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
-55.06
|
-35.78
|
5.88
|
26.76
|
95.94
|
|
Peer Median
|
21.60
|
15.05
|
15.01
|
23.50
|
--
|
Net Profit Growth
-43.28
Lower than Peers by 66.01
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
-43.28
|
-27.38
|
2.64
|
23.75
|
106.52
|
|
Peer Median
|
22.73
|
11.89
|
14.80
|
30.12
|
--
|
EPS Growth
-43.33
Lower than Peers by 63.36
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
-43.33
|
-25.89
|
1.38
|
23.60
|
106.27
|
|
Peer Median
|
20.03
|
12.16
|
14.27
|
29.02
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
12.99
|
18.78
|
21.53
|
21.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
0.20
|
0.14
|
0.07
|
0.06
|
|
Peer Median
|
0.00
|
0.05
|
0.06
|
0.03
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
0.16
|
0.11
|
0.05
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.80
Lower than Peers by 0.28
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
1.80
|
1.79
|
1.92
|
2.59
|
2.38
|
|
Peer Median
|
2.08
|
1.93
|
1.90
|
2.23
|
--
|
Quick Ratio
1.35
Lower than Peers by 0.19
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
1.35
|
1.34
|
1.37
|
1.92
|
1.82
|
|
Peer Median
|
1.54
|
1.52
|
1.46
|
1.59
|
--
|
Interest Coverage
10.67
Lower than Peers by 8.70
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
10.67
|
15.43
|
28.15
|
43.09
|
43.36
|
|
Peer Median
|
19.38
|
19.95
|
24.96
|
45.29
|
--
|
Operating Efficiency
Debtors to sales
30.47
Higher than Peers by 9.09
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
30.47
|
30.04
|
27.70
|
28.67
|
29.38
|
|
Peer Median
|
21.38
|
19.87
|
21.77
|
20.10
|
--
|
Asset Turnover
0.62
Lower than Peers by 0.10
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
0.62
|
0.65
|
0.76
|
0.81
|
0.82
|
|
Peer Median
|
0.72
|
0.77
|
0.76
|
0.81
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
103.79
|
95.44
|
99.54
|
103.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
79.94
|
75.27
|
73.12
|
73.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
84.78
|
96.23
|
108.56
|
108.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
--
|
98.95
|
74.48
|
64.10
|
68.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
30.44
Lower than Peers by 3.32
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
30.44
|
24.97
|
16.87
|
3.68
|
3.42
|
|
Peer Median
|
33.76
|
34.32
|
26.81
|
39.85
|
--
|
Price / Book Value
2.57
Lower than Peers by 2.35
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
2.57
|
2.78
|
2.86
|
3.65
|
3.33
|
|
Peer Median
|
4.92
|
5.12
|
4.65
|
6.11
|
--
|
Dividend Yield
0.68
Higher than Peers by 0.18
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
0.68
|
0.64
|
0.70
|
0.65
|
0.87
|
|
Peer Median
|
0.50
|
0.51
|
0.61
|
0.37
|
--
|
EV/EBITDA
15.61
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
15.61
|
13.97
|
10.12
|
11.66
|
10.35
|
|
Peer Median
|
--
|
30.38
|
27.02
|
34.57
|
--
|
Market Cap
98,075
Higher than Peers by 78,928
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
98,075
|
1,04,764
|
95,415
|
1,02,669
|
76,994
|
|
Peer Median
|
19,147
|
18,013
|
20,914
|
25,297
|
--
|